GlassScriptPhysician profile
Paige C White
NPI 1194825216
$6,877.06
in general payments reported to CMS, 2019-2025
19 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $109 · 2021: $136 · 2022: $2,526 · 2023: $2,491 · 2024: $443 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,782 · Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,782.21 |
| Food and Beverage | $1,494.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,640.24 | 2022-2024 | Axonics, Bulkamid |
| Coloplast Corp | $495.69 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $493.75 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $223.07 | 2019-2021 | |
| Urovant Sciences INC | $196.24 | 2022 | |
| Allergan, INC. | $151.01 | 2019-2022 | |
| Boston Scientific Corporation | $131.20 | 2020-2025 | Axonics |
| Medtronic, INC. | $126.85 | 2022-2023 | Interstim |
| Siemens Medical Solutions USA, INC. | $91.89 | 2024 | Magnetom Vida |
| Olympus America INC. | $69.24 | 2020-2025 | Uretero-Reno Videoscope |
| Medtronic USA, INC. | $69.08 | 2019 | |
| Urogen Pharma, INC. | $46.32 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $43.70 | 2019 | |
| Kerecis Limited | $21.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Endo Pharmaceuticals INC. | $20.80 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $17.05 | 2019 | |
| Abbvie INC. | $14.67 | 2023 | Botox |
| Teleflex LLC | $12.57 | 2021 | |
| Pfizer INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.